ijms-logo

Journal Browser

Journal Browser

Molecular Mechanisms of Rheumatoid Arthritis 2.0

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".

Deadline for manuscript submissions: closed (30 November 2021) | Viewed by 2837

Special Issue Editors


E-Mail Website
Guest Editor
Università degli Studi di Roma La Sapienza, Rome, Italy
Interests: systemic lupus erythematosus; rheumatoid arthritis; biological and synthetic targets of DMARDs
Special Issues, Collections and Topics in MDPI journals

E-Mail
Guest Editor
Rheumatology, Department of Internal Medicine University Hospital " Shefqet Ndroqi" Tirana, Albania
Interests: systemic lupus erythematosus; rheumatoid arthritis; biological and synthetic targets of DMARDs
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Rheumatoid arthritis is the most common inflammatory arthritis, affecting 1–2% of the population. The disease is characterized by autoantibody production, synovial inflammation leading to the destruction of cartilage and bone, and systemic inflammation responsible for extra-articular manifestations. Despite the great advances in the knowledge of the pathogenesis of rheumatoid arthritis, many aspects remain to be clarified. The Special Issue “Molecular Mechanisms of Rheumatoid Arthritis” will focus on the wide spectrum of molecular mechanisms involved in the pathogenesis and clinical expression of rheumatoid arthritis, as well as their possible contribution to treatment response and precision medicine. We invite authors to contribute to this Special Issue with original research and review articles focusing on, but not limited to, epigenetic mechanisms, host–pathogen interactions, cell death mechanisms, post-translational modifications, innate and adaptive immunity and non-immune cells (synovial fibroblasts, osteoclasts, endothelial cells) and mechanisms of inflammation resolution. We will consider papers addressing these mechanisms from a pathogenic point of view and/or exploring potential biomarkers of clinical expression/severity of the disease and therapeutic response suggesting stratified treatment options and predictive biomarkers.

Dr. Francesca Romana Spinelli
Dr. Arbi Pecani
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • rheumatoid arthritis
  • epigenetic
  • cell death
  • post-translational modifications
  • resolution of inflammation
  • precision medicine

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 11660 KiB  
Article
Sustained Hypoxia Suppresses Joint Destruction in a Rat Model of Rheumatoid Arthritis via Negative Feedback of Hypoxia Inducible Factor-1α
by Kenta Kaihara, Shuji Nakagawa, Yuji Arai, Hiroaki Inoue, Shinji Tsuchida, Yuta Fujii, Yoichiro Kamada, Tsunao Kishida, Osam Mazda and Kenji Takahashi
Int. J. Mol. Sci. 2021, 22(8), 3898; https://doi.org/10.3390/ijms22083898 - 09 Apr 2021
Cited by 8 | Viewed by 2118
Abstract
Hypoxia inducible factor (HIF)-1α has been implicated in the pathogenesis of rheumatoid arthritis (RA). HIF-1α, which is expressed in hypoxia, is reversely suppressed in sustained hypoxia. Here, we investigated the inhibitory effect of hypoxia on arthritis by controlling HIF-1α. Rheumatoid fibroblast-like synoviocyte MH7A [...] Read more.
Hypoxia inducible factor (HIF)-1α has been implicated in the pathogenesis of rheumatoid arthritis (RA). HIF-1α, which is expressed in hypoxia, is reversely suppressed in sustained hypoxia. Here, we investigated the inhibitory effect of hypoxia on arthritis by controlling HIF-1α. Rheumatoid fibroblast-like synoviocyte MH7A cells were cultured in a hypoxic incubator for up to 72 h to evaluate the expression of HIF-1. Furthermore, collagen-induced arthritis (CIA) model rats were maintained under 12% hypoxia in a hypoxic chamber for 28 days to evaluate the effect on arthritis. In MH7A cells, HIF-1α protein level increased at 3 h, peaked at 6 h, and subsequently decreased in a time-dependent manner. The transcription of pro-inflammatory cytokines increased at 1 h; however, they decreased after 3 h (p < 0.05). Deferoxamine-mediated activation of HIF-1α abolished the inhibitory effect of sustained hypoxia on pro-inflammatory cytokines. In the rat CIA model, the onset of joint swelling was delayed and arthritis was suppressed in the hypoxia group compared with the normoxia group (p < 0.05). Histologically, joint destruction was suppressed primarily in the cartilage. Thus, sustained hypoxia may represent a new safe, and potent therapeutic approach for high-risk patients with RA by suppressing HIF-1α expression. Full article
(This article belongs to the Special Issue Molecular Mechanisms of Rheumatoid Arthritis 2.0)
Show Figures

Figure 1

Back to TopTop